相关实验视频
Updated: Jul 2, 2025
08:50
Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
39.7K
介导ERK-cPLA2-ACSL4轴的M2巨细胞铁死阻碍了性结肠炎的粘膜愈合
Yulin Ye1, Limin Liu1, Zelin Feng1
1Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, Tianjin, China; Tianjin Institute of Digestive Diseases, Tianjin, China; Tianjin Key Laboratory of Digestive Diseases, Tianjin, China.
Free radical biology & medicine
|February 17, 2024
概括
将5-氨基酸 (5-ASA) 与ferroptosis抑制剂 (如Fer-1) 结合起来,可以通过减少结肠巨细胞中的ferroptosis并促进愈合来改善性结肠炎 (UC) 治疗.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病.
- 5-氨基酸 (5-ASA) 是一种标准的UC治疗方法,但其疗效有限.
- 结肠细胞中过度的铁亡可能会阻碍粘膜的愈合和UC治疗的成功.
研究的目的:
- 为了研究铁化在UC病变发生中的作用.
- 探索将5-ASA与铁灭抑制剂结合用于UC治疗的潜力.
- 阐明UC巨细胞中铁灭易感性背后的机制.
主要方法:
- 在体外和体外UC的模型.
- 使用 Fer-1 的铁酶抑制.
- 巨细胞的表型化 (M1/M2).
- 阿拉基酸 (AA) 代谢途径的分析.
- 基因表达分析 (cPLA2).
- 有针对性的代谢学.
主要成果:
- 单独使用5-ASA治疗并不能完全预防UC结肠细胞中的铁亡.
- 与5-ASA和Fer-1的联合治疗显著抑制了铁和增加了M2巨细胞.
- M2巨细胞比M1巨细胞更容易受到铁亡的影响.
- 这种敏感性与ERK-cPLA2-ACSL4通路和UC患者cPLA2基因表达增加有关.
- 组合疗法调节了AA代谢.
结论:
- 向M2巨细胞中的铁亡是一种潜在的UC治疗策略.
- 抑制铁亡可以增强巨细胞的抗炎功能,并促进UC的粘膜愈合.
- 与5-ASA和铁灭抑制剂的联合治疗可能为UC患者提供更好的结果.
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
141
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
141
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
184
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
184